Today: 18 July 2026
American Airlines Stock Price Today: AAL Climbs as Falling Oil Eases Jet-Fuel Fears
25 March 2026
1 min read

American Airlines Stock Price Today: AAL Climbs as Falling Oil Eases Jet-Fuel Fears

NEW YORK, March 25, 2026, 09:49 EDT

American Airlines Group (AAL) popped 3.6% to $11.10 early Wednesday, with airline stocks broadly higher as crude tumbled on optimism for a possible U.S.-Iran thaw. United Airlines added 3.7%, Delta Air Lines ticked up 2.0%. Brent crude slipped roughly 4%, hovering close to $100 a barrel.

Fuel now stands as airlines’ second-biggest expense, right behind labor, typically eating up 20% to 25% of operating costs—and most U.S. carriers have dropped hedging. American Airlines last week reported that pricier fuel had tacked on about $400 million to its first-quarter costs since late January. Still, the company raised its revenue growth target to above 10% and expects its adjusted loss to hit the lower end of its prior forecast. CEO Robert Isom pointed to stronger-than-anticipated revenue trends, saying that momentum carried over into April and May.

Investors are balancing robust demand with the risks tied to fuel prices. American doesn’t have the same buffer as Delta, which operates the Monroe refinery outside Philadelphia. Instead, American sources fuel on the open market—so when the crack spread widens, meaning the gap between crude and refined products like jet fuel opens up, American’s exposure increases.

Delta is basically pocketing the crack spread on some of its own fuel, Morningstar’s Nicolas Owens pointed out, easing the blow from soaring refining margins. CEO Ed Bastian described the refinery as a “meaningful hedge”—something American lacks. Reuters

United is already plotting its next move. Last week, Chief Executive Scott Kirby warned the airline could slash roughly five percentage points of its scheduled capacity this year if fuel prices don’t ease. He also pointed to steady demand, saying it’s letting airlines push fares higher to offset some of those added costs.

American said Tuesday it added Mary Dillon—who previously led Foot Locker and Ulta Beauty—to its board, where she’ll sit on the compensation and governance committees. CEO Isom pointed to her background in operations, commercial strategy, and marketing as assets for the company.

The stock’s been tracking oil’s moves. American jumped 3.66% Monday—crude had dropped over 10% after President Donald Trump announced a hold on strikes against Iranian power plants. But Tuesday saw Wall Street retreat, oil rebounding, and investors unsure if diplomacy would stick.

The rally isn’t locked in. Amundi’s Amelie Derambure noted traders are eyeing a “relief rally,” but ING’s Chris Turner thinks it’s “too early” to bank on a sharp decline in energy prices. Should crude rebound, the fuel costs for American will rise right alongside, bringing back the margin squeeze management just highlighted last week. Reuters

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Viking Therapeutics slips 4.6%, keeps obesity trial valuation edge
    July 18, 2026, 1:15 PM EDT. Viking Therapeutics (NASDAQ:VKTX) fell 4.6% this week but continues to trade at an 86% cash-adjusted valuation premium over Structure Therapeutics (NASDAQ:GPCR). Viking's injectable obesity candidates are in Phase 3, supporting its clinical-stage premium amid higher expenses and a broader loss forecast for 2026. At March 31, Viking reported $603 million in cash, while Structure held $1.46 billion, providing funding through mid-2027 and late 2028, respectively. Analysts like William Blair's Andy Hsieh maintain a Buy rating. Second-quarter results, due July 29, will spotlight cash burn, R&D spending and study outcomes. According to Viking's CEO, the oral VK2735 candidate achieved encouraging efficacy, delivering notable weight loss over 13 weeks compared with placebo.
Coeur Mining Stock Near $18 After New Gold Deal, $750 Million Buyback and First Dividend
Previous Story

Coeur Mining Stock Near $18 After New Gold Deal, $750 Million Buyback and First Dividend

Dow Jones Today: Why the Index Is Slipping as Oil Jumps and Fed Cut Hopes Fade
Next Story

Dow Jones Today: Why the Index Is Slipping as Oil Jumps and Fed Cut Hopes Fade

Go toTop